HitGen Inc., Chengdu, Sichuan 610200, China.
ACS Chem Biol. 2023 Jan 20;18(1):25-33. doi: 10.1021/acschembio.2c00797. Epub 2023 Jan 6.
The proteolysis targeting chimera (PROTAC) strategy results in the down-regulation of unwanted protein(s) for disease treatment. In the PROTAC process, a heterobifunctional degrader forms a ternary complex with a target protein of interest (POI) and an E3 ligase, which results in ubiquitination and proteasomal degradation of the POI. While ternary complex formation is a key attribute of PROTAC degraders, modification of the PROTAC molecule to optimize ternary complex formation and protein degradation can be a labor-intensive and tedious process. In this study, we take advantage of DNA-encoded library (DEL) technology to efficiently synthesize a vast number of possible PROTAC molecules and describe a parallel screening approach that utilizes DNA barcodes as reporters of ternary complex formation and cooperative binding. We use a designed PROTAC DEL against BRD4 and CRBN to describe a dual protein affinity selection method and the direct discovery of novel, potent BRD4 PROTACs that importantly demonstrate clear SAR. Such an approach evaluates all the potential PROTACs simultaneously, avoids the interference of PROTAC solubility and permeability, and uses POI and E3 ligase proteins in an efficient manner.
蛋白水解靶向嵌合体(PROTAC)策略可导致下调不需要的蛋白质以治疗疾病。在 PROTAC 过程中,杂双功能降解剂与靶蛋白(POI)和 E3 连接酶形成三元复合物,导致 POI 的泛素化和蛋白酶体降解。虽然三元复合物的形成是 PROTAC 降解剂的关键属性,但为了优化三元复合物的形成和蛋白质降解而对 PROTAC 分子进行修饰可能是一项劳动密集型且繁琐的过程。在这项研究中,我们利用 DNA 编码文库(DEL)技术来高效合成大量可能的 PROTAC 分子,并描述了一种平行筛选方法,该方法利用 DNA 条码作为三元复合物形成和协同结合的报告器。我们使用针对 BRD4 和 CRBN 的设计的 PROTAC DEL 来描述双蛋白亲和选择方法和直接发现新型、有效的 BRD4 PROTAC,这些 PROTAC 重要地证明了明确的 SAR。这种方法可同时评估所有潜在的 PROTAC,避免了 PROTAC 溶解度和通透性的干扰,并有效地利用 POI 和 E3 连接酶蛋白。